Aleva raises $13.7 million in series A

Aleva Neurotherapeutics S.A. (Lausanne, Switzerland) raised EUR 9.5 million ($13.7 million) in a series A round co-led by BioMedInvest and BB Biotech. Initiative Capital Romandie and private investors...